A Clinical Study of HT-101 and HT-102 in Patients With Chronic Hepatitis B Virus Infection

NCT07245953 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: HT-101
DRUG: HT-102
DRUG: HT-101 placebo
DRUG: HT-102 placebo

Sponsor

Suzhou HepaThera Biotech Co., Ltd.